Last Price Today's Change   Day's Range   Trading Volume
0.395   -0.005 (1.25%)  0.39 - 0.405  719,332


Avg Volume (4 weeks):986,766
4 Weeks Range:0.39 - 0.55
4 Weeks Price Volatility (%):
52 Weeks Range:0.105 - 0.78
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Orthocell Limited is a regenerative medicine company. The Company is engaged in the development and commercialization of cell therapies and related technologies. The Company's products include CelGro, a collagen medical device for soft tissue repair in use as an augment to rotator cuff repair, guided bone regeneration and repair of articular cartilage, and Autologous Tenocyte Implantation (Ortho-ATI) for chronic, treatment resistant tendon regeneration. CelGro is targeted on a range of orthopedic, reconstructive and surgical applications. Ortho-ATI is a treatment that uses a minimally invasive, non-surgical approach that uses each patient's own tendon derived stem cells to stimulate tendon regeneration and is delivered through ultrasound guided injection under local anesthetic. The Company's Autologous Chondrocyte Implantation (Ortho-ACI) offers treatment for symptomatic defects of the articulating cartilage of the joints, including the knee and ankle.

  Be the first to like this.


521  644  690  9313 

Top 10 Active Counters
 CAZ 0.045+0.02 
 BPH 0.0010.00 
 TLS 3.67-0.11 
 GRB 0.092-0.001 
 BAS 0.001-0.001 
 NWE 0.004+0.001 
 NCZ 0.285+0.02 
 ADN 0.054+0.002 
 BLK 0.013+0.001 
 GTG 0.006+0.001 
Partners & Brokers